DEO Diageo | $83.12 +1.0% | 3/7/2018 | | Downgrade | | Buy ➝ Neutral | 00.00% | View details for Natixis rating of Diageo (NYSE:DEO) on 3/7/2018 |
BNPQY BNP Paribas | $60.04 +1.9% | 2/13/2018 | | Upgrade | | Neutral ➝ Buy | 00.00% | View details for Natixis rating of BNP Paribas (OTCMKTS:BNPQY) on 2/13/2018 |
AZN AstraZeneca | £126.70 -0.1% | 9/6/2017 | | Upgrade | GBX 5,000 ➝ GBX 5,738 | Neutral ➝ Buy | 00.00% | View details for Natixis rating of AstraZeneca (LON:AZN) on 9/6/2017 |
AZN Astrazeneca | $168.68 +0.2% | 9/6/2017 | | Upgrade | | Neutral ➝ Buy | 00.00% | View details for Natixis rating of Astrazeneca (NYSE:AZN) on 9/6/2017 |
CRRFY Carrefour | $3.56 -3.3% | 8/31/2017 | | Downgrade | | Buy ➝ Neutral | 00.00% | View details for Natixis rating of Carrefour (OTCMKTS:CRRFY) on 8/31/2017 |
CRRFY Carrefour | $3.56 -3.3% | 8/31/2017 | | Reiterated Rating | | Buy ➝ Neutral | 00.00% | View details for Natixis rating of Carrefour (OTCMKTS:CRRFY) on 8/31/2017 |
CTTAY Continental | $7.94 +1.0% | 7/18/2017 | | Upgrade | | Neutral ➝ Buy | 00.00% | View details for Natixis rating of Continental (OTCMKTS:CTTAY) on 7/18/2017 |
PHG Koninklijke Philips | $26.16 +0.5% | 6/21/2017 | | Downgrade | | Buy ➝ Neutral | 00.00% | View details for Natixis rating of Koninklijke Philips (NYSE:PHG) on 6/21/2017 |
IBDRY Iberdrola | $96.46 +0.7% | 6/8/2017 | | Reiterated Rating | | Buy ➝ Neutral | 00.00% | View details for Natixis rating of Iberdrola (OTCMKTS:IBDRY) on 6/8/2017 |
BCS Barclays | $27.93 +1.0% | 5/4/2017 | | Downgrade | | Buy ➝ Neutral | 00.00% | View details for Natixis rating of Barclays (NYSE:BCS) on 5/4/2017 |
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
|
CABGY Carlsberg AS | $27.69 -0.7% | 3/29/2017 | | Upgrade | | Neutral ➝ Buy | 00.00% | View details for Natixis rating of Carlsberg AS (OTCMKTS:CABGY) on 3/29/2017 |
NWG NatWest Group | $17.97 +0.6% | 3/17/2017 | | Upgrade | | Reduce ➝ Buy | 00.00% | View details for Natixis rating of NatWest Group (NYSE:NWG) on 3/17/2017 |
DB Deutsche Bank Aktiengesellschaft | $34.66 +1.5% | 3/6/2017 | | Reiterated Rating | | Reduce | 00.00% | View details for Natixis rating of Deutsche Bank Aktiengesellschaft (NYSE:DB) on 3/6/2017 |
DBVT DBV Technologies | $13.63 -1.7% | 2/17/2017 | | Upgrade | | Neutral ➝ Buy | 00.00% | View details for Natixis rating of DBV Technologies (NASDAQ:DBVT) on 2/17/2017 |
VLEEY Valeo | $7.83 -2.2% | 2/17/2017 | | Downgrade | | Buy ➝ Neutral | 00.00% | View details for Natixis rating of Valeo (OTCMKTS:VLEEY) on 2/17/2017 |
SNY Sanofi | $43.35 0.0% | 2/9/2017 | | Upgrade | | Neutral ➝ Buy | 00.00% | View details for Natixis rating of Sanofi (NASDAQ:SNY) on 2/9/2017 |
ABBNY ABB | $96.36 -1.5% | 2/8/2017 | | Upgrade | | Neutral ➝ Buy | 00.00% | View details for Natixis rating of ABB (OTCMKTS:ABBNY) on 2/8/2017 |
NOK Nokia | $9.07 -6.7% | 1/13/2017 | | Upgrade | | Neutral ➝ Buy | 00.00% | View details for Natixis rating of Nokia (NYSE:NOK) on 1/13/2017 |
HSBA HSBC | GBX 1,552.80 +1.7% | 11/17/2016 | | Reiterated Rating | GBX 478 ➝ GBX 672 | Neutral | 00.00% | View details for Natixis rating of HSBC (LON:HSBA) on 11/17/2016 |
HSBC HSBC | $103.35 +1.6% | 11/17/2016 | | Upgrade | | Reduce ➝ Neutral | 00.00% | View details for Natixis rating of HSBC (NYSE:HSBC) on 11/17/2016 |
WPP WPP | GBX 282.50 +3.7% | 11/1/2016 | | Boost Price Target | GBX 1,600 ➝ GBX 1,650 | Neutral | 00.00% | View details for Natixis rating of WPP (LON:WPP) on 11/1/2016 |
GSK GSK | GBX 1,919.50 +0.7% | 10/27/2016 | | Reiterated Rating | GBX 1,750 | Neutral | 00.00% | View details for Natixis rating of GSK (LON:GSK) on 10/27/2016 |
LLOY Lloyds Banking Group | GBX 113.50 +0.9% | 10/27/2016 | | Reiterated Rating | GBX 56 | Neutral | 00.00% | View details for Natixis rating of Lloyds Banking Group (LON:LLOY) on 10/27/2016 |
ERIC Ericsson | $9.33 +0.2% | 10/13/2016 | | Downgrade | | Buy ➝ Neutral | 00.00% | View details for Natixis rating of Ericsson (NASDAQ:ERIC) on 10/13/2016 |
SAN Banco Santander | $13.53 +2.4% | 10/11/2016 | | Upgrade | | Reduce ➝ Buy | 00.00% | View details for Natixis rating of Banco Santander (NYSE:SAN) on 10/11/2016 |
BUD Anheuser-Busch InBev SA/NV | $81.67 +1.5% | 8/3/2016 | | Upgrade | | Reduce ➝ Neutral | 00.00% | View details for Natixis rating of Anheuser-Busch InBev SA/NV (NYSE:BUD) on 8/3/2016 |
NWG NatWest Group | $17.97 +0.6% | 7/18/2016 | | Downgrade | | Neutral ➝ Reduce | 00.00% | View details for Natixis rating of NatWest Group (NYSE:NWG) on 7/18/2016 |
FERG Ferguson | GBX 228.67 -0.4% | 6/2/2016 | | Reiterated Rating | GBX 3,900 | Neutral | 00.00% | View details for Natixis rating of Ferguson (LON:FERG) on 6/2/2016 |
PSON Pearson | GBX 1,226 +1.8% | 5/18/2016 | | Reiterated Rating | GBX 1,150 | Buy | 00.00% | View details for Natixis rating of Pearson (LON:PSON) on 5/18/2016 |
CCL Carnival Co. & | GBX 1,903.50
| 3/31/2016 | | Boost Price Target | GBX 4,200 ➝ GBX 4,300 | Buy | 00.00% | View details for Natixis rating of Carnival Co. & (LON:CCL) on 3/31/2016 |
ABBNY ABB | $96.36 -1.5% | 3/28/2016 | | Upgrade | $25.50 | Neutral ➝ Buy | 00.00% | View details for Natixis rating of ABB (OTCMKTS:ABBNY) on 3/28/2016 |
ASML ASML | $1,757.09 -2.5% | 3/28/2016 | | Lower Price Target | $83.00 ➝ $80.00 | Buy | 00.00% | View details for Natixis rating of ASML (NASDAQ:ASML) on 3/28/2016 |
AZN AstraZeneca | £126.70 -0.1% | 3/24/2016 | | Reiterated Rating | GBX 4,456 | Neutral | 00.00% | View details for Natixis rating of AstraZeneca (LON:AZN) on 3/24/2016 |
PSON Pearson | GBX 1,226 +1.8% | 3/24/2016 | | Reiterated Rating | GBX 1,150 | Buy | 00.00% | View details for Natixis rating of Pearson (LON:PSON) on 3/24/2016 |
PSON Pearson | GBX 1,226 +1.8% | 3/17/2016 | | Reiterated Rating | GBX 1,150 | Buy | 00.00% | View details for Natixis rating of Pearson (LON:PSON) on 3/17/2016 |
WTB Whitbread | GBX 2,437 +1.9% | 3/15/2016 | | Reiterated Rating | GBX 4,000 | Neutral | 00.00% | View details for Natixis rating of Whitbread (LON:WTB) on 3/15/2016 |
LLOY Lloyds Banking Group | GBX 113.50 +0.9% | 3/11/2016 | | Reiterated Rating | GBX 85 | Buy | 00.00% | View details for Natixis rating of Lloyds Banking Group (LON:LLOY) on 3/11/2016 |
PSON Pearson | GBX 1,226 +1.8% | 3/8/2016 | | Reiterated Rating | GBX 1,150 | Buy | 00.00% | View details for Natixis rating of Pearson (LON:PSON) on 3/8/2016 |
WPP WPP | GBX 282.50 +3.7% | 3/7/2016 | | Boost Price Target | GBX 1,400 ➝ GBX 1,410 | Neutral | 00.00% | View details for Natixis rating of WPP (LON:WPP) on 3/7/2016 |
BARC Barclays | GBX 521.56 +0.4% | 3/3/2016 | | Reiterated Rating | GBX 212 | Buy | 00.00% | View details for Natixis rating of Barclays (LON:BARC) on 3/3/2016 |
Trump’s emergency dollar reset (Ad) Bloomberg research shows the U.S. dollar's share of global reserves has fallen to the lowest level this century — and the consequences for your savings and investments could be severe.
President Trump has signed executive order 14241 to initiate the first full reset of the American dollar in 50 years. A new monetary anchor is being established — one that's not gold or crypto, but something far more unexpected that Vladimir Putin once called the key to world leadership. Read the full story on what this dollar reset means for your portfolio |
PSON Pearson | GBX 1,226 +1.8% | 2/29/2016 | | Reiterated Rating | GBX 1,150 | Buy | 00.00% | View details for Natixis rating of Pearson (LON:PSON) on 2/29/2016 |
LLOY Lloyds Banking Group | GBX 113.50 +0.9% | 2/26/2016 | | Reiterated Rating | GBX 85 | Buy | 00.00% | View details for Natixis rating of Lloyds Banking Group (LON:LLOY) on 2/26/2016 |
STAN Standard Chartered | GBX 2,134.29 +0.2% | 2/25/2016 | | Lower Price Target | GBX 522 ➝ GBX 374 | Neutral | 00.00% | View details for Natixis rating of Standard Chartered (LON:STAN) on 2/25/2016 |
AZN AstraZeneca | £126.70 -0.1% | 2/24/2016 | | Reiterated Rating | GBX 4,456 | Neutral | 00.00% | View details for Natixis rating of AstraZeneca (LON:AZN) on 2/24/2016 |
WPP WPP | GBX 282.50 +3.7% | 2/17/2016 | | Reiterated Rating | GBX 1,400 | Neutral | 00.00% | View details for Natixis rating of WPP (LON:WPP) on 2/17/2016 |
LRLCY L'Oreal | $84.75 +1.3% | 2/9/2016 | | Upgrade | | Neutral ➝ Buy | 00.00% | View details for Natixis rating of L’Oreal (OTCMKTS:LRLCY) on 2/9/2016 |
AZN AstraZeneca | £126.70 -0.1% | 1/26/2016 | | Reiterated Rating | GBX 4,456 | Neutral | 00.00% | View details for Natixis rating of AstraZeneca (LON:AZN) on 1/26/2016 |
WPP WPP | GBX 282.50 +3.7% | 1/22/2016 | | Downgrade | GBX 1,400 | Neutral | 00.00% | View details for Natixis rating of WPP (LON:WPP) on 1/22/2016 |
HSBA HSBC | GBX 1,552.80 +1.7% | 1/20/2016 | | Downgrade | GBX 487 ➝ GBX 433 | Reduce | 00.00% | View details for Natixis rating of HSBC (LON:HSBA) on 1/20/2016 |
LLOY Lloyds Banking Group | GBX 113.50 +0.9% | 1/20/2016 | | Reiterated Rating | GBX 85 | Buy | 00.00% | View details for Natixis rating of Lloyds Banking Group (LON:LLOY) on 1/20/2016 |
GSK GSK | GBX 1,919.50 +0.7% | 1/13/2016 | | Reiterated Rating | GBX 1,470 | Neutral | 00.00% | View details for Natixis rating of GSK (LON:GSK) on 1/13/2016 |
CCL Carnival Co. & | GBX 1,903.50
| 12/21/2015 | | Boost Price Target | GBX 3,800 ➝ GBX 4,200 | Buy | 00.00% | View details for Natixis rating of Carnival Co. & (LON:CCL) on 12/21/2015 |
HSBA HSBC | GBX 1,552.80 +1.7% | 12/21/2015 | | Reiterated Rating | GBX 487 | Neutral | 00.00% | View details for Natixis rating of HSBC (LON:HSBA) on 12/21/2015 |
STAN Standard Chartered | GBX 2,134.29 +0.2% | 12/10/2015 | | Upgrade | GBX 522 | Neutral | 00.00% | View details for Natixis rating of Standard Chartered (LON:STAN) on 12/10/2015 |
HSBA HSBC | GBX 1,552.80 +1.7% | 12/8/2015 | | Reiterated Rating | GBX 487 | Neutral | 00.00% | View details for Natixis rating of HSBC (LON:HSBA) on 12/8/2015 |
CPG Compass Group | GBX 30.31 -0.5% | 12/4/2015 | | Boost Price Target | GBX 1,070 ➝ GBX 1,100 | Neutral | 00.00% | View details for Natixis rating of Compass Group (LON:CPG) on 12/4/2015 |
PSON Pearson | GBX 1,226 +1.8% | 12/4/2015 | | Reiterated Rating | GBX 1,400 | Buy | 00.00% | View details for Natixis rating of Pearson (LON:PSON) on 12/4/2015 |
STAN Standard Chartered | GBX 2,134.29 +0.2% | 12/3/2015 | | Reiterated Rating | GBX 548 | Reduce | 00.00% | View details for Natixis rating of Standard Chartered (LON:STAN) on 12/3/2015 |
DGE Diageo | GBX 1,553.50 +0.8% | 12/1/2015 | | Reiterated Rating | GBX 2,060 | Buy | 00.00% | View details for Natixis rating of Diageo (LON:DGE) on 12/1/2015 |
PSON Pearson | GBX 1,226 +1.8% | 11/25/2015 | | Reiterated Rating | GBX 1,400 | Buy | 00.00% | View details for Natixis rating of Pearson (LON:PSON) on 11/25/2015 |
CPG Compass Group | GBX 30.31 -0.5% | 11/18/2015 | | Reiterated Rating | GBX 1,070 | Neutral | 00.00% | View details for Natixis rating of Compass Group (LON:CPG) on 11/18/2015 |
AZN AstraZeneca | £126.70 -0.1% | 11/12/2015 | | Reiterated Rating | GBX 4,456 | Neutral | 00.00% | View details for Natixis rating of AstraZeneca (LON:AZN) on 11/12/2015 |
FERG Ferguson | GBX 228.67 -0.4% | 11/11/2015 | | Reiterated Rating | GBX 3,900 | Neutral | 00.00% | View details for Natixis rating of Ferguson (LON:FERG) on 11/11/2015 |
ECIFY Electricité de France | $2.55
| 11/9/2015 | | Reiterated Rating | $20.00 ➝ $19.00 | Neutral | 00.00% | View details for Natixis rating of Electricité de France (OTCMKTS:ECIFY) on 11/9/2015 |
STAN Standard Chartered | GBX 2,134.29 +0.2% | 11/6/2015 | | Reiterated Rating | GBX 548 | Reduce | 00.00% | View details for Natixis rating of Standard Chartered (LON:STAN) on 11/6/2015 |
AZN AstraZeneca | £126.70 -0.1% | 11/4/2015 | | Reiterated Rating | GBX 4,456 | Neutral | 00.00% | View details for Natixis rating of AstraZeneca (LON:AZN) on 11/4/2015 |
GSK GSK | GBX 1,919.50 +0.7% | 11/4/2015 | | Reiterated Rating | GBX 1,470 | Neutral | 00.00% | View details for Natixis rating of GSK (LON:GSK) on 11/4/2015 |
HSBA HSBC | GBX 1,552.80 +1.7% | 11/3/2015 | | Lower Price Target | GBX 495 ➝ GBX 487 | Neutral | 00.00% | View details for Natixis rating of HSBC (LON:HSBA) on 11/3/2015 |
BARC Barclays | GBX 521.56 +0.4% | 10/30/2015 | | Lower Price Target | GBX 292 ➝ GBX 283 | Buy | 00.00% | View details for Natixis rating of Barclays (LON:BARC) on 10/30/2015 |
WPP WPP | GBX 282.50 +3.7% | 10/27/2015 | | Lower Price Target | GBX 1,750 ➝ GBX 1,660 | Buy | 00.00% | View details for Natixis rating of WPP (LON:WPP) on 10/27/2015 |
GSK GSK | GBX 1,919.50 +0.7% | 10/26/2015 | | Reiterated Rating | GBX 1,470 | Neutral | 00.00% | View details for Natixis rating of GSK (LON:GSK) on 10/26/2015 |
AZN AstraZeneca | £126.70 -0.1% | 10/25/2015 | | Reiterated Rating | GBX 4,456 | Neutral | 00.00% | View details for Natixis rating of AstraZeneca (LON:AZN) on 10/25/2015 |
IHG InterContinental Hotels Group | GBX 154.69 +0.9% | 10/21/2015 | | Reiterated Rating | GBX 2,600 | Neutral | 00.00% | View details for Natixis rating of InterContinental Hotels Group (LON:IHG) on 10/21/2015 |
WTB Whitbread | GBX 2,437 +1.9% | 10/21/2015 | | Reiterated Rating | GBX 5,050 | Neutral | 00.00% | View details for Natixis rating of Whitbread (LON:WTB) on 10/21/2015 |
AZN AstraZeneca | £126.70 -0.1% | 10/19/2015 | | Lower Price Target | GBX 4,628 ➝ GBX 4,456 | Neutral | 00.00% | View details for Natixis rating of AstraZeneca (LON:AZN) on 10/19/2015 |
PSON Pearson | GBX 1,226 +1.8% | 10/19/2015 | | Reiterated Rating | GBX 1,550 | Buy | 00.00% | View details for Natixis rating of Pearson (LON:PSON) on 10/19/2015 |
BCS Barclays | $27.93 +1.0% | 10/16/2015 | | Initiated Coverage | | Buy | 00.00% | View details for Natixis rating of Barclays (NYSE:BCS) on 10/16/2015 |
ING ING Group | $32.84 +1.2% | 10/9/2015 | | Initiated Coverage | | Buy | 00.00% | View details for Natixis rating of ING Group (NYSE:ING) on 10/9/2015 |
AZN AstraZeneca | £126.70 -0.1% | 10/7/2015 | | Reiterated Rating | GBX 4,628 | Neutral | 00.00% | View details for Natixis rating of AstraZeneca (LON:AZN) on 10/7/2015 |
GSK GSK | GBX 1,919.50 +0.7% | 10/7/2015 | | Reiterated Rating | GBX 1,470 | Neutral | 00.00% | View details for Natixis rating of GSK (LON:GSK) on 10/7/2015 |
VOD Vodafone Group Public | GBX 115.15 -0.9% | 10/5/2015 | | Reiterated Rating | GBX 224 | Neutral | 00.00% | View details for Natixis rating of Vodafone Group Public (LON:VOD) on 10/5/2015 |
FERG Ferguson | GBX 228.67 -0.4% | 9/30/2015 | | Lower Price Target | GBX 4,300 ➝ GBX 3,900 | Neutral | 00.00% | View details for Natixis rating of Ferguson (LON:FERG) on 9/30/2015 |
WPP WPP | GBX 282.50 +3.7% | 9/30/2015 | | Reiterated Rating | GBX 1,750 | Buy | 00.00% | View details for Natixis rating of WPP (LON:WPP) on 9/30/2015 |
DEO Diageo | $83.12 +1.0% | 9/24/2015 | | Reiterated Rating | | Buy | 00.00% | View details for Natixis rating of Diageo (NYSE:DEO) on 9/24/2015 |
DGE Diageo | GBX 1,553.50 +0.8% | 9/24/2015 | | Lower Price Target | GBX 2,170 ➝ GBX 1,990 | Buy | 00.00% | View details for Natixis rating of Diageo (LON:DGE) on 9/24/2015 |
CCL Carnival Co. & | GBX 1,903.50
| 9/23/2015 | | Boost Price Target | GBX 3,600 ➝ GBX 3,800 | Buy | 00.00% | View details for Natixis rating of Carnival Co. & (LON:CCL) on 9/23/2015 |
WTB Whitbread | GBX 2,437 +1.9% | 9/15/2015 | | Lower Price Target | GBX 5,300 ➝ GBX 5,050 | Neutral | 00.00% | View details for Natixis rating of Whitbread (LON:WTB) on 9/15/2015 |
STM STMicroelectronics | $51.39 -3.9% | 9/14/2015 | | Lower Price Target | $10.50 ➝ $9.10 | Buy | 00.00% | View details for Natixis rating of STMicroelectronics (NYSE:STM) on 9/14/2015 |
GSK GSK | GBX 1,919.50 +0.7% | 9/9/2015 | | Lower Price Target | GBX 1,500 ➝ GBX 1,470 | Neutral | 00.00% | View details for Natixis rating of GSK (LON:GSK) on 9/9/2015 |
PSON Pearson | GBX 1,226 +1.8% | 9/3/2015 | | Reiterated Rating | GBX 1,550 | Buy | 00.00% | View details for Natixis rating of Pearson (LON:PSON) on 9/3/2015 |
Have you seen Elon’s new “supercurrency”? (It affects you) (Ad) Elon Musk just became the world's first trillionaire following the biggest IPO in history, giving him access to what millionaire trader Tim Bohen calls a rare supercurrency.
Tim believes this shift could ripple into a handful of small, overlooked stocks in the coming weeks. Watch Tim's free video breakdown before this story develops further |
PSON Pearson | GBX 1,226 +1.8% | 8/13/2015 | | Reiterated Rating | GBX 1,550 | Buy | 00.00% | View details for Natixis rating of Pearson (LON:PSON) on 8/13/2015 |
DGE Diageo | GBX 1,553.50 +0.8% | 6/26/2015 | | Reiterated Rating | GBX 2,170 | Buy | 00.00% | View details for Natixis rating of Diageo (LON:DGE) on 6/26/2015 |
CCL Carnival Co. & | GBX 1,903.50
| 6/24/2015 | | Reiterated Rating | GBX 3,600 | buy | 00.00% | View details for Natixis rating of Carnival Co. & (LON:CCL) on 6/24/2015 |
PSON Pearson | GBX 1,226 +1.8% | 6/18/2015 | | Reiterated Rating | GBX 1,550 | Buy | 00.00% | View details for Natixis rating of Pearson (LON:PSON) on 6/18/2015 |
VIVHY Vivendi | $2.09 +1.0% | 6/18/2015 | | Downgrade | | Buy ➝ Neutral | 00.00% | View details for Natixis rating of Vivendi (OTCMKTS:VIVHY) on 6/18/2015 |
FERG Ferguson | GBX 228.67 -0.4% | 6/12/2015 | | Reiterated Rating | GBX 4,300 | Neutral | 00.00% | View details for Natixis rating of Ferguson (LON:FERG) on 6/12/2015 |
DEO Diageo | $83.12 +1.0% | 6/9/2015 | | Upgrade | | Neutral ➝ Buy | 00.00% | View details for Natixis rating of Diageo (NYSE:DEO) on 6/9/2015 |
DGE Diageo | GBX 1,553.50 +0.8% | 6/9/2015 | | Upgrade | GBX 1,950 ➝ GBX 2,170 | Buy | 00.00% | View details for Natixis rating of Diageo (LON:DGE) on 6/9/2015 |
PSON Pearson | GBX 1,226 +1.8% | 6/8/2015 | | Reiterated Rating | GBX 1,550 | Buy | 00.00% | View details for Natixis rating of Pearson (LON:PSON) on 6/8/2015 |
HDELY Heidelberg Materials | $24.93
| 6/5/2015 | | Upgrade | | Reduce ➝ Neutral | 00.00% | View details for Natixis rating of Heidelberg Materials (OTCMKTS:HDELY) on 6/5/2015 |